AstraZeneca Investors Rejoice After COPD Drug Performs in Phase IV Study Post author:Sam Post published:December 3, 2017 Post category:BioPharma Tudorza, also marketed as Eklira and Bretaris, is available in more than 50 countries. Source: BioSpace You Might Also Like <b>Vividion Therapeutics</b> Launches With $50 Million and a Celgene Alum as Executive Chairman February 1, 2017 Astellas Takes a $387 Million+ Loss as It Shuts Down SoCal's Agensys, Inc. July 26, 2017 3 Best Biotherapeutics Stocks to Buy Right Now February 1, 2018
<b>Vividion Therapeutics</b> Launches With $50 Million and a Celgene Alum as Executive Chairman February 1, 2017
